These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 8765195)
1. Expression of basic fibroblast growth factor and its mRNA in uterine endometrial cancers. Fujimoto J; Hori M; Ichigo S; Tamaya T Invasion Metastasis; 1995; 15(5-6):203-10. PubMed ID: 8765195 [TBL] [Abstract][Full Text] [Related]
2. Expressions of the fibroblast growth factor family (FGF-1, -2 and -4) mRNA in endometrial cancers. Fujimoto J; Hori M; Ichigo S; Tamaya T Tumour Biol; 1996; 17(4):226-33. PubMed ID: 8685603 [TBL] [Abstract][Full Text] [Related]
3. Expression of protease activated receptor-2 related to angiogenesis in tumor advancement of uterine endometrial cancers. Jahan I; Fujimoto J; Alam SM; Sato E; Sakaguchi H; Tamaya T Oncol Rep; 2007 Feb; 17(2):345-50. PubMed ID: 17203172 [TBL] [Abstract][Full Text] [Related]
4. Plausible linkage of hypoxia-inducible factor (HIF) in uterine endometrial cancers. Fujimoto J; Sato E; Alam SM; Jahan I; Toyoki H; Hong BL; Sakaguchi H; Tamaya T Oncology; 2006; 71(1-2):95-101. PubMed ID: 17341889 [TBL] [Abstract][Full Text] [Related]
5. Expression of platelet-derived endothelial cell growth factor (PD-ECGF) and its mRNA in uterine endometrial cancers. Fujimoto J; Ichigo S; Sakaguchi H; Hirose R; Tamaya T Cancer Lett; 1998 Aug; 130(1-2):115-20. PubMed ID: 9751263 [TBL] [Abstract][Full Text] [Related]
6. Expression of interferon-gamma-inducible protein 10 related to angiogenesis in uterine endometrial cancers. Sato E; Fujimoto J; Tamaya T Oncology; 2007; 73(3-4):246-51. PubMed ID: 18424889 [TBL] [Abstract][Full Text] [Related]
7. [Expression of pituitary tumor-transforming gene in endometrial carcinoma]. Wang YK; Cui N; Li J; Luo B Zhonghua Fu Chan Ke Za Zhi; 2004 Aug; 39(8):538-42. PubMed ID: 15363353 [TBL] [Abstract][Full Text] [Related]
8. Ovine endometrial expression of fibroblast growth factor (FGF) 2 and conceptus expression of FGF receptors during early pregnancy. Ocón-Grove OM; Cooke FN; Alvarez IM; Johnson SE; Ott TL; Ealy AD Domest Anim Endocrinol; 2008 Feb; 34(2):135-45. PubMed ID: 17223006 [TBL] [Abstract][Full Text] [Related]
9. Differential mRNA expression of urokinase-type plasminogen activator, plasminogen activator receptor and plasminogen activator inhibitor type-2 in normal human endometria and endometrial carcinomas. Foca C; Moses EK; Quinn MA; Rice GE Gynecol Oncol; 2000 Nov; 79(2):244-50. PubMed ID: 11063652 [TBL] [Abstract][Full Text] [Related]
10. Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density. Hague S; Zhang L; Oehler MK; Manek S; MacKenzie IZ; Bicknell R; Rees MC Clin Cancer Res; 2000 Jul; 6(7):2808-14. PubMed ID: 10914728 [TBL] [Abstract][Full Text] [Related]
11. Expressions of vascular endothelial growth factor (VEGF) and its mRNA in uterine endometrial cancers. Fujimoto J; Ichigo S; Hirose R; Sakaguchi H; Tamaya T Cancer Lett; 1998 Dec; 134(1):15-22. PubMed ID: 10381125 [TBL] [Abstract][Full Text] [Related]
12. [Endocrinological contribution for invasion and metastasis in gynecological cancers]. Fujimoto J Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):633-43. PubMed ID: 8808831 [TBL] [Abstract][Full Text] [Related]
13. Sex steroid-dependent angiogenesis in uterine endometrial cancers. Fujimoto J; Toyoki H; Jahan I; Alam SM; Sakaguchi H; Sato E; Tamaya T J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):161-5. PubMed ID: 15860258 [TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor C gene expression is closely related to invasion phenotype in gynecological tumor cells. Ueda M; Terai Y; Kumagai K; Ueki K; Yamaguchi H; Akise D; Ueki M Gynecol Oncol; 2001 Jul; 82(1):162-6. PubMed ID: 11426979 [TBL] [Abstract][Full Text] [Related]
15. [Preoperative platelet count as index of the grading in endometrial carcinoma]. Giannella L; Menozzi G; Di Monte I; Venturini P; De Pace V; Boselli F; Ternelli G; Jasonni VM Minerva Ginecol; 2008 Aug; 60(4):273-9. PubMed ID: 18560341 [TBL] [Abstract][Full Text] [Related]
16. Expression of vascular endothelial growth factor (VEGF) and its mRNA in uterine cervical cancers. Fujimoto J; Sakaguchi H; Hirose R; Ichigo S; Tamaya T Br J Cancer; 1999 May; 80(5-6):827-33. PubMed ID: 10360662 [TBL] [Abstract][Full Text] [Related]
17. Drastic decrease of progesterone receptor form B but not A mRNA reflects poor patient prognosis in endometrial cancers. Sakaguchi H; Fujimoto J; Hong BL; Nakagawa Y; Tamaya T Gynecol Oncol; 2004 May; 93(2):394-9. PubMed ID: 15099952 [TBL] [Abstract][Full Text] [Related]
18. Oestrogen regulated gene expression in normal and malignant endometrial tissue. O'Toole SA; Dunn E; Sheppard BL; Sheils O; O'Leary JJ; Wuttke W; Seidlova-Wuttke D Maturitas; 2005 Jun; 51(2):187-98. PubMed ID: 15917160 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of the fibroblast growth factor receptor-1 gene correlates with liver metastasis in colorectal cancer. Sato T; Oshima T; Yoshihara K; Yamamoto N; Yamada R; Nagano Y; Fujii S; Kunisaki C; Shiozawa M; Akaike M; Rino Y; Tanaka K; Masuda M; Imada T Oncol Rep; 2009 Jan; 21(1):211-6. PubMed ID: 19082464 [TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor gamma and growth inhibition by its ligands in uterine endometrial carcinoma. Ota K; Ito K; Suzuki T; Saito S; Tamura M; Hayashi S; Okamura K; Sasano H; Yaegashi N Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4200-8. PubMed ID: 16857792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]